Usa state Florida state Minnesota state Arizona state Wisconsin covid-19 patient Health Usa state Florida state Minnesota state Arizona state Wisconsin

News Scan for Aug 30, 2021

Reading now: 526
www.cidrap.umn.edu

Antibody combo lowers hospitalizations in high-risk COVID-19 patientsHigh-risk adults with mild to moderate COVID-19 who receive a dose of casirivimab and imdevimab have lower hospitalization rates than those who don't, according to a randomized, controlled trial today in The Lancet's EClinicalMedicine.

The casirivimab and imdevimab combination is under emergency use authorization by the US Food and Drug Administration.Mayo Clinic researchers paired 696 intervention patients with 696 control patients from Arizona, Florida, Minnesota, and Wisconsin from Dec 4, 2020, to Apr 9, 2021.

All were at high risk: 45.5% were 65 or older, and common underlying conditions included high blood pressure (52.4%), body mass index (BMI) of 35 kg/m2 or higher

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA